References

C-reactive protein-albumin-lymphocyte (CALLY) index as an independent risk factor for postoperative atrial fibrillation recurrence

10.1002/clc.70157 · ExternalCitation · doi-reference

Inflammatory biomarkers in heart failure: clinical perspectives on hsCRP, IL-6 and emerging candidates

10.1007/s11897-025-00710-3 · ExternalCitation · doi-reference

Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchronization therapy

10.1016/j.cardfail.2006.11.013 · ExternalCitation · doi-reference

Nutritional interventions in heart failure: a systematic review of the literature

10.1016/j.cardfail.2015.10.004 · ExternalCitation · doi-reference

Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: a state-of-the-art review

10.1016/j.hrthm.2024.05.057 · ExternalCitation · doi-reference

A retrospective study on the association between C-reactive protein-albumin-lymphocyte (CALLY) index and adverse prognosis in patients with chronic heart failure (CHF) at different glucose metabolic states

10.1016/j.hrtlng.2025.102693 · ExternalCitation · doi-reference

Implication of geriatric nutritional risk index on treatment response and long-term prognosis in patients with cardiac resynchronization therapy

10.1016/j.ijcard.2024.132064 · ExternalCitation · doi-reference

Prognostic significance of c-reactive protein-albuminlymphocyte (CALLY) index after primary percutaneous coronary intervention in patients with ST- segment elevation myocardial infarction

10.1016/j.intimp.2024.112860 · ExternalCitation · doi-reference

Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up

10.1016/j.jacc.2008.10.032 · ExternalCitation · doi-reference

Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation

10.1016/j.jacc.2010.05.049 · ExternalCitation · doi-reference

C-reactive protein and risk of incident heart failure in patients with cardiovascular disease

10.1016/j.jacc.2023.05.035 · ExternalCitation · doi-reference

Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990–2023

10.1016/j.jacc.2025.08.015 · ExternalCitation · doi-reference

Clinical implications of c-reactive protein-albumin-lymphocyte (CALLY) index in patients with esophageal cancer

10.1016/j.suronc.2024.102044 · ExternalCitation · doi-reference

Global epidemiology of heart failure

10.1038/s41569-024-01046-6 · ExternalCitation · doi-reference

Comparison of c-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

10.1056/nejmoa021993 · ExternalCitation · doi-reference

Global burden of heart failure: a comprehensive and updated review of epidemiology

10.1093/cvr/cvac013 · ExternalCitation · doi-reference

2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy

10.1093/eurheartj/ehab364 · ExternalCitation · doi-reference

European Society of Cardiology (ESC) clinical consensus statement on indications for conduction system pacing, with special contribution of the European heart rhythm association of the ESC and endorsed by the Asia Pacific Heart Rhythm Society, the Canadian Heart Rhythm Society, the Heart Rhythm Society, and the Latin American Heart Rhythm Society

10.1093/europace/euaf050 · ExternalCitation · doi-reference

Conduction system vs. biventricular pacing in heart failure with reduced ejection fraction: a meta-analysis of randomized controlled trials

10.1093/europace/euag170 · ExternalCitation · doi-reference

Prognostic importance of the controlling nutritional status (CONUT) score in patients undergoing cardiac resynchronisation therapy

10.1136/openhrt-2021-001740 · ExternalCitation · doi-reference

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

10.1161/01.res.0000043825.01705.1b · ExternalCitation · doi-reference

2022 AHA/ACC/HFSA guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines

10.1161/cir.0000000000001063 · ExternalCitation · doi-reference

Cardiac inflammation impedes response to cardiac resynchronization therapy in patients with idiopathic dilated cardiomyopathy

10.1161/circep.120.008727 · ExternalCitation · doi-reference

Trajectory of C-reactive protein and incident heart failure in black adults: the Jackson heart study

10.1161/circheartfailure.123.011199 · ExternalCitation · doi-reference

C-reactive protein-albumin-lymphocyte (CALLY) index and length of hospital stay in patients with heart failure

10.1177/00033197251355348 · ExternalCitation · doi-reference

Metabolic syndrome, high-sensitivity c-reactive protein and the risk of heart failure: the Kailuan cohort study

10.3389/fendo.2025.1544823 · ExternalCitation · doi-reference

Role of C-reactive protein at sites of inflammation and infection

10.3389/fimmu.2018.00754 · ExternalCitation · doi-reference

Association of CALLY index and CLR with COPD risk in middle-aged and older Americans: evidence from NHANES 2017–2020

10.3389/fmed.2025.1535415 · ExternalCitation · doi-reference

Stretch, injury and inflammation markers evaluation to predict clinical outcomes after implantable cardioverter defibrillator therapy in heart failure patients with metabolic syndrome

10.3389/fphys.2018.00758 · ExternalCitation · doi-reference

Galectin-3, inflammation, and the risk of atrial high-rate episodes in patients with dual chamber pacemakers

10.3390/ijms24097710 · ExternalCitation · doi-reference

The effect of cardiac resynchronization therapy on right ventricular function: a systematic review and meta-analysis

10.3390/jcm13144173 · ExternalCitation · doi-reference